to work primarily on mAbs for Malaria, a disease which disproportionately impacts the developing world, and COVID-19 mAbs
- Funded by Gates Foundation
- Total publications:0 publications
Grant number: INV-004259
Grant search
Key facts
Disease
COVID-19start year
2020Known Financial Commitments (USD)
$1,310,303Funder
Gates FoundationPrincipal Investigator
N/A
Research Location
United States of AmericaLead Research Institution
Curia Bio, Inc.Research Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
N/A